Developments ACAAI presentations highlight new data from DBV’s trial of peanut patch in allergic children DBV Technologies (Euronext: DBV; ISIN: FR0010417345; NASDAQ: DBVT) has announced that three presentations at the American College of Allergy, Asthma & Immunology (ACAAI) 2026 Annual Scientific Meeting in Phoenix... November 12, 2026